Immunocellular Therapeutics, Ltd. (IMUC) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts IMUC Hot Sheet
Join SI Premium – FREE
Immunocellular Therapeutics, Ltd. (NYSE: IMUC) reported Q2 EPS of $0.04, $0.10 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Immunocellular Therapeutics, Ltd. (IMUC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Serve Robotics names Andreas Lieber to its board of directors
- FuelCell Energy signs deal with Fit Energy for up to 380 MW of power
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
